Concepedia

Jeanette Musser

JM

Statistics

Publications

2

Citations

38

H-Index

2

Active since

2015

Affiliations

Agilent Technologies (Germany)(Current)

Jeanette Musser is an author at Agilent Technologies (Germany) specializing in immuno-oncology biomarkers, cancer biomarkers, and pd-l1 blockade.

Publications per year

2015–2021

2

Publications

2

Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDx

Megan Kalpakoff, Stephanie Hund, Jeanette Musser et al. · Applied immunohistochemistry & molecular morphology · 2021 · 28 citations · Full text

, , +14

Development of a PD-L1 immunohistochemistry (IHC) assay for use as a companion diagnostic for pembrolizumab (MK-3475) in non-small cell lung cancer (NSCLC).

Marisa Dolled‐Filhart, Charlotte Roach, Grant Toland et al. · Journal of Clinical Oncology · 2015 · 10 citations

, , +17

1–2 of 2